Surrogate endpoints that looked good on paper and failed in patients

Popularity Index: 1 Updated at 2026-10-11 09:20 UTC

Sites

Related Topics

What evidence does a regulator need before a drug goes to market? Interpreting an effect size that is statistically significant but tiny Genetic evidence vs epidemiological evidence in the same causal claim How much of a manuscript's statistics can a non-statistician referee check? Observational data vs a randomized trial on the same exposure Two meta-analyses of the same question reaching opposite conclusions Subgroup analyses that look convincing and mean nothing Reading a forest plot without fooling yourself Can reviewers really judge statistics without the raw data? Why a percentage change hides the size of the base it came from

Hot Categories

Featured Categories